Evidence map›Paper›PMID 41608591›Full record

ArticleFrontiers in molecular neuroscience2025

Gene expression asymmetry in Parkinson's disease: variation of

Steven E Pierce, Edwin J C van der Schans, Thomas M Goralski, Elizabeth Ensink, Peipei Li, Michael X Henderson, Gerhard A Coetzee

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Steven E PierceDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Edwin J C van der SchansDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Thomas M GoralskiDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Elizabeth EnsinkDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Peipei LiDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Michael X HendersonDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.
Gerhard A CoetzeeDepartment of Neurodegenerative Science, Van Andel Institute, Grand Rapids, MI, United States.

Funding

Epigenetic contributions to symptom asymmetry in Parkinson's diseaseR01NS113894 · NINDS · VAN ANDEL RESEARCH INSTITUTE · PI COETZEE, GERHARD A · 2020 to 2024
$2.2M
NINDS NIH HHS R01 NS113894
6 · The paper itself

Abstract

Parkinson's disease (PD) symptom onset is typically unilateral, which may be related to molecular differences underlying hemispheric vulnerability. Here we sampled prefrontal cortex bilaterally from people with PD and healthy controls and performed RNA-seq on neuronal nuclei to determine hemispheric and disease-related differences. Brain hemispheres were categorized based on whether they corresponded to the side of symptom onset (severe) or the opposite side (moderate) and compared for differences in gene expression. We employed two

Indexed as

asymmetrybrain lateralizationCCTchaperoninParkinson’s disease

Identifiers

PMID41608591
PMCPMC12835222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.